
Myomo (MYO) Stock Forecast & Price Target
Myomo (MYO) Analyst Ratings
Bulls say
Myomo is well-positioned for long-term growth due to its focus on commercialization, recent product launches, upcoming key catalysts in 2026, and solid sales and backlog numbers. The positive Medicare ruling and potential for expansion into international markets signify a potential for increased revenue and earnings in the future. However, there are some risks to consider, such as balance sheet and liquidity concerns, regulatory approvals, competition, and changes in market and consumer trends.
Bears say
Myomo is a young company with a potentially valuable product, but the risks associated with its market, reliance on insurance companies and VA, and lack of profits at this point outweigh the potential rewards. While the company has potential for growth in the future, the current negative financials and dependence on external factors present significant concerns for investors.
This aggregate rating is based on analysts' research of Myomo and is not a guaranteed prediction by Public.com or investment advice.
Myomo (MYO) Analyst Forecast & Price Prediction
Start investing in Myomo (MYO)
Order type
Buy in
Order amount
Est. shares
0 shares